Exact Mass: 219.14305180000002
Exact Mass Matches: 219.14305180000002
Found 72 metabolites which its exact mass value is equals to given mass value 219.14305180000002,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Miglustat
Miglustat is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. It is only used for patients who cannot be treated with enzyme replacement therapy with imiglucerase. It is marketed under the trade name Zavesca. Miglustat is now the first and only approved therapy for patients with Niemann-Pick disease type C (NP-C). It has recently been approved for treatment of progressive neurological symptoms in adult and pediatric patients in the European Union, Brazil, and South Korea. A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors C471 - Enzyme Inhibitor > C2846 - Glucosidase Inhibitor D004791 - Enzyme Inhibitors
1-hydroperoxy-8-carboxyoctyl-3,4-epoxynon-(2E)-enyl-ether
C12H18BNO2 (219.14305180000002)
1-hydroperoxy-8-carboxyoctyl-3,4-epoxynon-(2E)-enyl-ether is considered to be practically insoluble (in water) and basic
Cimaterol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists CONFIDENCE standard compound; EAWAG_UCHEM_ID 3657
3-[2-(Morpholinomethyl)-1H-pyrrol-1-yl]propanenitrile
1-Propanamine, 3-(1H-indazol-3-yloxy)-N,N-dimethyl-
2-Hydroxymethyl-5-(1-hydroxypentyl)-3,4-pyrrolidinediol
miglustat
A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors C471 - Enzyme Inhibitor > C2846 - Glucosidase Inhibitor D004791 - Enzyme Inhibitors
pyrrolidin-1-yl(4,5,6,7-tetrahydro-3H-benzimidazol-5-yl)methanone
(S)-TERT-BUTYL (1,5-DIHYDROXYPENTAN-2-YL)CARBAMATE
1-METHYL-4-(PIPERIDIN-4-YL)PIPERAZINE HYDROCHLORIDE
(2-(PIPERIDIN-1-YLMETHYL)PHENYL)BORONIC ACID
C12H18BNO2 (219.14305180000002)
1-benzyl-piperidine-4-boronic acid
C12H18BNO2 (219.14305180000002)
2-Methylpyridine-5-boronic acid pinacol ester
C12H18BNO2 (219.14305180000002)
2-Methylpyridine-3-boronic acid pinacol ester
C12H18BNO2 (219.14305180000002)
6-Methylpyridine-2-boronic acid pinacol ester
C12H18BNO2 (219.14305180000002)
4-METHYLPYRIDINE-2-BORONIC ACID PINACOL ESTER
C12H18BNO2 (219.14305180000002)
2-Aminophenylboronic acid pinacol ester
C12H18BNO2 (219.14305180000002)
5-Methylpyridine-2-boronic acid pinacol ester
C12H18BNO2 (219.14305180000002)
4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
C12H18BNO2 (219.14305180000002)
PIPERIDINE-4-CARBOXYLIC ACID (4-METHYL-PYRIDIN-2-YL)-AMIDE
PIPERIDINE-3-CARBOXYLIC ACID (6-METHYL-PYRIDIN-2-YL)-AMIDE
PIPERIDINE-4-CARBOXYLIC ACID (6-METHYL-PYRIDIN-2-YL)-AMIDE
PIPERIDINE-4-CARBOXYLIC ACID (5-METHYL-PYRIDIN-2-YL)-AMIDE
PIPERIDINE-3-CARBOXYLIC ACID (4-METHYL-PYRIDIN-2-YL)-AMIDE
8,8-Dimethyl-9-oxa-2-azaspiro[5.5]undecane hydrochloride (1:1)
C11H22ClNO (219.13898319999998)
2-[(diethylamino)methyl]cyclohexanone hydrochloride
C11H22ClNO (219.13898319999998)
(6-AMINOPYRIDIN-2-YL)(1-METHYLPIPERIDIN-4-YL)METHANONE
3-(1-Pyrrolidinoethyl)phenylboronic acid
C12H18BNO2 (219.14305180000002)
3-Picoline-5-boronic acid pinacolate
C12H18BNO2 (219.14305180000002)
3-aminophenylboronic acid pinacol ester
C12H18BNO2 (219.14305180000002)
2-Methylpyridine-4-boronic acid pinacol ester
C12H18BNO2 (219.14305180000002)
3-Methylpyridine-4-boronic acid pinacol ester
C12H18BNO2 (219.14305180000002)
2-(2-Hydroxyethylamino)-1,6,7-trimethylbenzimidazole
3-Butyl-1,2-dimethyl-1H-imidazol-3-ium dicyanoazanide
2-(2-phenylethyl)-1,3,6,2-dioxazaborocane
C12H18BNO2 (219.14305180000002)
Lucerastat
C471 - Enzyme Inhibitor Lucerastat, the galactose form of Miglustat, is an orally-available inhibitor of glucosylceramide synthase (GCS). Lucerastat has the potential for Fabry disease study[1][2].
Cinobufotenine
C13H19N2O+ (219.14973039999998)
D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
4-hydroxy-N,N,N-trimethyltryptamine
C13H19N2O+ (219.14973039999998)
5-HTQ
C13H19N2O+ (219.14973039999998)
D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
6-c-butyl-dmdp
{"Ingredient_id": "HBIN012289","Ingredient_name": "6-c-butyl-dmdp","Alias": "NA","Ingredient_formula": "C10H21NO4","Ingredient_Smile": "CCCCC(C1C(C(C(N1)CO)O)O)O","Ingredient_weight": "219.28 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2792","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10443411","DrugBank_id": "NA"}